<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>p53 overexpression was studied immunohistochemically in paraffin-embedded bone marrow biopsies using a recently described technique for antigen retrieval based on microwave oven heating of paraffin sections </plain></SENT>
<SENT sid="1" pm="."><plain>Using a monoclonal antibody (PAb1801) that reacts with human cellular p53, nuclear staining was detected in 7/11 (63%) therapy-related <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> and in 3/4 (75%) therapy-related <z:hpo ids='HP_0004808'>acute myeloid leukemias</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Conversely, staining for p53 was seen only in 9/40 (22%) cases of "primary" hematologic conditions (P &lt; 0.007); these included <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> [#2], <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> [#4], and <z:hpo ids='HP_0011010'>chronic</z:hpo> granulocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> in accelerated phase or <z:e sem="disease" ids="C0005699" disease_type="Neoplastic Process" abbrv="">blast crisis</z:e> [#3] </plain></SENT>
<SENT sid="3" pm="."><plain>Biopsies of <z:mpath ids='MPATH_458'>normal</z:mpath> controls and of <z:hpo ids='HP_0011010'>chronic</z:hpo> granulocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> in stable phase were consistently p53(-) </plain></SENT>
<SENT sid="4" pm="."><plain>Nine of the 10 karyotyped p53(+) <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo>/<z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> cases showed complex cytogenetic findings with frequent involvement of chromosome 5 and/or 7 </plain></SENT>
<SENT sid="5" pm="."><plain>Only four of the 33 karyotyped p53(-) cases showed similar cytogenetic changes </plain></SENT>
<SENT sid="6" pm="."><plain>Chromosome 17 involvement was present in four of 13 (31%) cytogenetically assessed p53+ cases, but in none of the p53(-) </plain></SENT>
<SENT sid="7" pm="."><plain>In univariate analysis, p53 expression in both <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> was significantly associated with shorter survival </plain></SENT>
<SENT sid="8" pm="."><plain>The frequent overexpression of p53 in therapy-related <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo>, therapy-related <z:hpo ids='HP_0004808'>acute myeloid leukemias</z:hpo> and in accelerated phase/<z:e sem="disease" ids="C0005699" disease_type="Neoplastic Process" abbrv="">blast crisis</z:e>, <z:hpo ids='HP_0011010'>chronic</z:hpo> granulocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> and its strong association with complex karyotypes suggests an important role of this gene in the pathogenesis of these leukemic conditions </plain></SENT>
</text></document>